Bactiguard Holding AB (CHIX:BACTBS) Other Operating Expense: kr187.8 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:BACTBS Bactiguard Holding AB CHIX:BACTBS
56 GF Score
Price kr128.60
GF Value kr257.35
! 3 Warning Signs
View Full Analysis

What is Bactiguard Holding AB Other Operating Expense?

Bactiguard Holding AB CHIX:BACTBS 56 Other Operating Expense is kr187.8 Mil as of Jun. 2026. GuruFocus rates CHIX:BACTBS with a GF Score™ of 56/100 and a GF Value™ of kr257.35. The stock has 3 warning signs investors should review.

Bactiguard Holding AB's Other Operating Expense for the three months ended in Jun. 2026 was kr53.4 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was kr187.8 Mil.

Bactiguard Holding AB's quarterly Other Operating Expense increased from Dec. 2025 (kr43.1 Mil) to Mar. 2026 (kr45.9 Mil) and increased from Mar. 2026 (kr45.9 Mil) to Jun. 2026 (kr53.4 Mil).

Bactiguard Holding AB's annual Other Operating Expense declined from Dec. 2023 (kr277.2 Mil) to Dec. 2024 (kr243.9 Mil) and declined from Dec. 2024 (kr243.9 Mil) to Dec. 2025 (kr192.2 Mil).

Bactiguard Holding AB Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Bactiguard Holding AB's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bactiguard Holding AB Other Operating Expense Chart

Bactiguard Holding AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 185.12 237.53 277.18 243.91 192.19

Bactiguard Holding AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.72 45.44 43.12 45.86 53.36
CHIX:BACTBS
56GF Score
Bactiguard Holding AB CHIX:BACTBS
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bactiguard Holding AB Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr187.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of kr187.8 Mil mean?
Bactiguard Holding AB (CHIX:BACTBS) has a Other Operating Expense of kr187.8 Mil as of Jun. 2026. Other operating expenses that a company records on its income statement. View historical data on Bactiguard Holding AB and its competitors.
Is Bactiguard Holding AB's Other Operating Expense too high?
Bactiguard Holding AB's current Other Operating Expense is kr187.8 Mil. Overall, Bactiguard Holding AB has a GF Score™ of 56/100, reflecting its overall financial health beyond just this single metric.
How does Bactiguard Holding AB's Other Operating Expense compare to ABT and SYK?
Bactiguard Holding AB's Other Operating Expense of kr187.8 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Medical Devices & Instruments company?
A good Other Operating Expense depends on the Medical Devices & Instruments industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Bactiguard Holding AB and its competitors. Bactiguard Holding AB's current Other Operating Expense is kr187.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bactiguard Holding AB stock overvalued right now?
Bactiguard Holding AB (CHIX:BACTBS) has a current Other Operating Expense of kr187.8 Mil. The stock's GF Value™ is kr257.35, compared to a current price of kr128.60 — trading 50% below its estimated fair value. The current Other Operating Expense is kr187.8 Mil. Bactiguard Holding AB's overall GF Score™ is 56/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Bactiguard Holding AB (CHIX:BACTBS), the current Other Operating Expense is kr187.8 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bactiguard Holding AB (CHIX:BACTBS) Overvalued in 2026?

Based on GuruFocus' analysis, Bactiguard Holding AB stock appears to be undervalued. The current stock price of kr128.60 is trading 50% below its estimated GF Value™ of kr257.35.

Key valuation signals for CHIX:BACTBS:

  • Other Operating Expense: kr187.8 Mil
  • GF Value™: kr257.35 vs. price of kr128.60 (50% below fair value)
  • GF Score™: 56/100 with 3 warning signs

No single metric tells the full story. See the CHIX:BACTBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bactiguard Holding AB Business Description

Other Exchanges BACTI B:Sweden5JE:Germany
Address Vasagatan 11, Stockholm, SWE, 111 20
Bactiguard Holding AB is a medical device company. It is engaged in a MedTech company developing safe and biocompatible technology to prevent medical device-related infections. The technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. The company focuses on five strategic therapeutic areas wherein infection rates create high medical needs for infection prevention. These areas include Orthopedics, Cardiology, Neurology, Urology, and Vascular Access. Geographically, the company operates in the USA, Malaysia, China, Saudi Arabia, Bangladesh, Sweden, the Czech Republic, and Other countries. The majority of its revenue is generated from the USA region.
56GF Score

Get the complete analysis for CHIX:BACTBS

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr128.60
Price
kr257.35
GF Value